Sarepta Therapeutics | SRPT - فروش و مدیریت هزینه

قیمت سهام
19.78
تغییر روزانه
-1.90 -8.76%
ماهیانه
21.20%
سالیانه
-71.91%
Q1 پیش بینی
23.06




فروش و مدیریت هزینه تغییر دادن تاریخ
Acadia Pharmaceuticals USD 146.73M 21.82M 2025-12
Agios Pharmaceuticals USD 42.97M 1.7M 2025-12
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
Amgen USD 1.94B 237M 2025-12
BioCryst Pharmaceuticals USD 95.78M 12.77M 2025-12
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Capricor Therapeutics USD 1.92M 446.47K 2025-12
Daiichi Sankyo JPY 228.23B 39.15B 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Esperion Therapeutics USD 39.42M 456K 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
Incyte USD 390.41M 61.33M 2025-12
Insmed USD 212.48M 26.11M 2025-12
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
Moderna USD 308M 40M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 301.8M 10.2M 2025-12
Novavax USD 25.53M 1.34M 2025-12
Pfizer USD 4.08B 894M 2025-12
PTC Therapeutics USD 87.2M 3.15M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sanofi EUR 2.75B 455M 2025-12
Sarepta Therapeutics USD 105.38M 28.27M 2025-12
Tectonic Therapeutic USD 3.44M 1.52M 2025-12
Ultragenyx Pharmaceutical USD 89M 2.38M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12